Skip to main content
63°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BMY
Recent news which mentions BMY
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Tickers
ABBV
BMY
NEWS
Tags
Market News
Large Cap
ABBV
From
Benzinga
Bristol Myers Squibb Presents Data For Multiple Sclerosis Drug Zeposia, Shows Long-Term Efficacy
September 18, 2024
Tickers
BMY
NEWS
Tags
News
Biotech
Health Care
From
Benzinga
What Analysts Are Saying About Bristol-Myers Squibb Stock
September 16, 2024
Tickers
BMY
Tags
BMY
Market News
BZI/AAR
From
Benzinga
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade
September 16, 2024
Tickers
BEP
BMY
RPRX
Tags
BMY
RPRX
Recent Press Releases
From
Motley Fool
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
September 14, 2024
Tickers
BMY
GILD
Tags
BMY
Recent Press Releases
Market News
From
Motley Fool
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
September 09, 2024
Tickers
BIIB
BMY
NEWS
Tags
News
Vermont
BIIB
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
BMY
PFE
Health Care
From
Benzinga
2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100
September 08, 2024
Tickers
BMY
RPRX
Tags
RPRX
BMY
Market News
From
Motley Fool
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
September 06, 2024
Tickers
BMRN
BMY
GSK
LLY
Tags
Biotech
Regulations
AI Generated
From
Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Tickers
AMGN
AZN
BMY
JNJ
Tags
Market News
Large Cap
Briefs
From
Benzinga
2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High
September 02, 2024
Tickers
BMY
Tags
BMY
Recent Press Releases
Market News
From
Motley Fool
2 No-Brainer Large-Cap Stocks to Buy With $500 Right Now
September 01, 2024
Tickers
BMY
HUBS
Tags
BMY
HUBS
Recent Press Releases
From
Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
August 30, 2024
Tickers
BMY
EIX
LUCY
O
Tags
pharmaceutical stocks
TRV
O
From
Benzinga
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
August 28, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
Health Care
BMY
Trading Ideas
From
Benzinga
Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday
August 28, 2024
Tickers
AIXI
AMBA
AVAV
AVPT
Tags
AVAV
mid/day
AIXI
From
Benzinga
3 High-Yield Dividend Stocks With Payout Ratios Below 75%
August 28, 2024
Tickers
BMY
CVX
T
Tags
CVX
Market News
Recent Press Releases
From
Motley Fool
2 Beaten-Down S&P 500 Dividend Stocks to Buy on the Dip and Hold Forever
August 28, 2024
Tickers
BMY
PFE
Tags
BMY
PFE
Market News
From
Motley Fool
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
August 27, 2024
Tickers
ABBV
BMY
LLY
NBIX
Tags
mental health
LLY
NBIX
From
Benzinga
Market Whales and Their Recent Bets on BMY Options
August 27, 2024
Tickers
BMY
Tags
Markets
Benzinga
Market News
From
Benzinga
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
August 23, 2024
Tickers
BGNE
BMY
MRK
NEWS
Tags
BGNE
Biotech
BMY
From
Benzinga
Key Takeaways From Bristol-Myers Squibb Analyst Ratings
August 22, 2024
Tickers
BMY
Tags
BMY
Analyst Ratings
Benzinga
From
Benzinga
Bristol-Myers Squibb's Options Frenzy: What You Need to Know
August 21, 2024
Tickers
BMY
Tags
Options
BZI/UOA
BMY
From
Benzinga
3 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
August 20, 2024
Tickers
BMY
CVS
DOW
Tags
Market News
CVS
Recent Press Releases
From
Motley Fool
Where Will Bristol Myers Squibb Be in 5 Years?
August 18, 2024
Tickers
BMY
Tags
BMY
Recent Press Releases
Market News
From
Motley Fool
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
August 18, 2024
Tickers
ADP
BMY
EIX
GNL
Tags
Recent Press Releases
GNL
EIX
From
Motley Fool
Check Out What Whales Are Doing With BMY
August 16, 2024
Tickers
BMY
Tags
Market News
Markets
Benzinga
From
Benzinga
Biden Administration Targets $6B Savings Through Medicare Drug Price Negotiations
August 15, 2024
Tickers
BMY
JNJ
LLY
MRK
Tags
MRK
BMY
Health Care
From
Benzinga
Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'
August 14, 2024
Tickers
BMY
EVO
NEWS
Tags
Briefs
General
Market News
From
Benzinga
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Tickers
ABBV
BMY
NEWS
RHHBY
Tags
why it's moving
Biotech
RHHBY
From
Benzinga
The 3 Best Healthcare Stocks to Buy in August 2024
August 12, 2024
Tickers
AMN
BMY
RAPP
Tags
AMN
Stocks to Buy
Market News
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.